Evaluation of a home blood collection kit for diabetes management
User Evaluation of a Home-collection Kit for People With Diabetes
This study is testing a home blood collection kit for people with diabetes to see if it helps them monitor their blood sugar levels more easily and effectively.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | University Hospitals of North Midlands NHS Trust Academic / other |
| Locations | 1 site (Stoke-on-Trent) |
| Trial ID | NCT06038669 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of a home-collection kit designed for individuals with diabetes. Participants will use a dried blood spot device to collect samples for HbA1c testing, which is crucial for monitoring blood glucose control. Healthcare professionals will conduct interviews to assess the usability and impact of the home-collection method on patient outcomes. The study seeks to improve diabetes management by facilitating more frequent monitoring outside of clinical settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and over who have been diagnosed with Type 1 or Type 2 diabetes.
Not a fit: Patients who do not speak English or have severe visual impairments may not benefit from this study due to challenges in understanding the procedures or completing the study tasks.
Why it matters
Potential benefit: If successful, this study could enhance diabetes management by allowing patients to monitor their blood glucose levels more conveniently and frequently.
How similar studies have performed: While there is ongoing research into home monitoring for diabetes, this specific approach using a dried blood spot device is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Type I or Type II diabetes * Aged 18 years or over * Venous blood sample for HbA1c collected within the two weeks prior to the clinic appointment * Ability to provide fully informed consent Exclusion Criteria: * Non-English speaking where translation of the study documents and procedures could limit fully informed consent * Severe visual impairment which would leave the participant unable to complete the study procedures.
Where this trial is running
Stoke-on-Trent
- University Hospitals of North Midlands NHS Trust — Stoke-on-Trent, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Aviva Ogbolosingha
- Email: aviva.ogbolosingha@uhnm.nhs.uk
- Phone: 01782 675380
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.